Follicular Lymphoma: Update on Diagnosis and Management

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Hematology".

Deadline for manuscript submissions: closed (1 June 2023) | Viewed by 528

Special Issue Editor


E-Mail Website
Guest Editor
Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Interests: DLBCL; FL; CAR T therapy; targeted therapy; epigenetics

Special Issue Information

Dear Colleagues,

Follicular lymphoma is an ever-evolving space with both a wealth and deficit of data on diagnosis, pathobiology of disease, early management, and relapse therapy. The variations of practice patterns across the globe contribute to the unique nature of managing the diversity of follicular lymphoma patients. While outcomes are improving, a cure still eludes patients. Hopefully, the research each of you carry out will one day make curing follicular lymphoma a reality. This Special Issue will provide a platform for developing a comprehensive understanding of diagnosis, prognosis, and management of follicular lymphoma with very special contributions from female lymphoma thought leaders.

Dr. Connie L. Batlevi
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • follicular lymphoma
  • diagnosis
  • management
  • prognosis
  • genetics
  • novel therapies

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop